Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
---|
10/20/1993 | EP0398925B1 Growth inhibiting agent and the use thereof |
10/19/1993 | US5254682 Cyclic renin inhibitors containing 3(S)-amino-4-cyclohexyl-2(R)-hydroxy-butanoic acid or 4-cyclo-hexyl-(2R, 3S)-dihydroxybutanoic acid or related analogs |
10/14/1993 | WO1993020047A1 Hydroxamic acid based collagenase and cytokine inhibitors |
10/12/1993 | US5252605 Promotion of wound-healing with 15-keto-prostaglandin compounds |
10/12/1993 | US5252591 Renin inhibitors |
10/12/1993 | US5252574 Hypotensive agents, vision disorder |
10/12/1993 | US5252571 Antidiabetic agents |
10/12/1993 | CA2093785A1 Benzimidazoles |
10/06/1993 | EP0564356A1 4-phenylaminomethylimidazole derivatives, process for their preparation, angiotensin II receptor antagonists and their application in therapy |
10/06/1993 | EP0564216A2 Pharmaceutical compositions for the treatment and/or prevention of degenerative disorders in the retina |
10/06/1993 | EP0563238A1 Imidazolyl-alkenoic acids |
10/06/1993 | CN1022325C Azolidinedione derovatives |
10/05/1993 | CA1322761C Organogermanium compounds and process for producing the same |
10/05/1993 | CA1322752C Heteroarylcarboxamide derivatives, process for preparing the same and pharmaceutical composition containing the same |
10/02/1993 | CA2093178A1 Pharmaceutical compositions for the treatment and/or prevention of degenerative disorders in the retina |
10/02/1993 | CA2092852A1 Imidazole derivatives, their method of preparation and their application in therapeutic |
09/30/1993 | WO1993018777A1 Use of mannose phosphates for the treatment of fibrotic disorders |
09/30/1993 | WO1993018772A1 Method for reducing intraocular pressure in the mammalian eye by administration of muscarinic antagonists |
09/30/1993 | WO1993018762A2 Method for reducing intraocular pressure in the mammalian eye by administration of gamma aminobutyric acid (gaba) agonists |
09/30/1993 | CA2132102A1 Method for reducing intraocular pressure in the mammalian eye by administration of gamma aminobutyric acid (gaba) agonists |
09/29/1993 | EP0562936A1 Imidazolines N-substituted by a biphenylmethyl group, their preparation, the pharmaceutical compositions containing them |
09/29/1993 | EP0562006A1 Homo-prostaglandin derivatives as ocular hypotensives |
09/29/1993 | EP0561913A1 Use of pyridine derivatives in the treatment of ocular hypertension |
09/29/1993 | EP0561905A1 Use of angiotensin ii receptor antagonists in the treatment of macular degeneration |
09/29/1993 | EP0561901A1 Use of angiotensin ii receptor antagonists in the treatment of diabetic retinopathy |
09/29/1993 | EP0561772A1 A new pharmaceutical use of fusidic acid and derivatives thereof |
09/28/1993 | US5248693 Acetylene compounds and pharmaceutical compositions and methods of using the same |
09/28/1993 | US5248504 Method of treatment for nasal and sinus dysfunction |
09/28/1993 | CA1322526C Chemical prevention or reversal of cataract by phase separation inhibitors |
09/28/1993 | CA1322524C Method and composition for ophthalmic anesthesia using rodocaine |
09/21/1993 | US5246944 Hypotensive and anxiolytic agents; antidepressants |
09/21/1993 | US5246940 Substituted n-biphenylyl lactams |
09/21/1993 | CA1322332C Protein c inhibitor (pci) as pharmaceutical and diagnostic aid a process for the preparation of a pharmaceutical or diagnostic aid of this type, and an agent containing pci |
09/21/1993 | CA1322328C Stabilized compositions containing epidermal growth factor |
09/16/1993 | WO1993017666A1 Method of treatment for nasal and sinus dysfunction, and horseradish preparation therefor |
09/16/1993 | CA2131458A1 Method of treatment for nasal and sinus dysfunction, and horseradish preparation therefor |
09/15/1993 | EP0559755A1 Substituted 5-aryl imidazoles |
09/15/1993 | EP0559724A1 Benzofuran and benzthiophene derivatives |
09/15/1993 | EP0559700A1 Novel pilocarpine derivatives and process for their preparation |
09/14/1993 | US5244889 Treatment of cardiovascular disorders |
09/08/1993 | EP0559279A1 Tetrahydropyrimidine derivatives |
09/07/1993 | US5242950 Treatment of macular degeneration |
09/07/1993 | US5242945 Tetronic and thiotetronic acid derivatives as phospholipase a2 inhibitors |
09/07/1993 | US5242942 Anticonvulsant fructopyranose cyclic sulfites and sulfates |
09/07/1993 | CA1322005C Benzoheterazoles |
09/07/1993 | CA1322004C Pyridyl styrene dialkanoic acids |
09/05/1993 | CA2090170A1 Tetrahydropyrimidine derivatives |
09/02/1993 | WO1993016724A1 Bystander suppression of autoimmune diseases |
09/02/1993 | WO1993016719A2 Use of platelet derived growth factor in ophthalmic wound healing |
09/02/1993 | WO1993016701A2 Topical antiglaucoma compositions comprising carbonic anhydrase inhibitors and beta-blockers |
09/02/1993 | WO1993010141A3 Angiostatic steroids |
09/02/1993 | CA2130748A1 Use of platelet derived growth factor in ophthalmic wound healing |
09/01/1993 | EP0557939A1 Aldose reductase inhibitor |
09/01/1993 | EP0557290A1 Treatment of aids dementia, myelopathy, peripheral neuropathy, and vision loss |
09/01/1993 | EP0316438B1 Chemical prevention or reversal of cataract by phase separation inhibitors |
09/01/1993 | CN1075632A Alkoxylated phenyl and coumarin derivatives and application thereof |
08/31/1993 | US5240953 Substituted triazoles as angiotensin ii inhibitors |
08/31/1993 | US5240950 Carbazate derivatives, their production and use |
08/31/1993 | US5240923 Treating glaucoma |
08/25/1993 | EP0556947A1 Use of M1-selective antimuscarinic pyridobenzodiazepinones for the treatment and prevention of axial myopia |
08/25/1993 | EP0556813A1 Amphoteric tricyclic compounds as antihistaminic and antiallergic agents |
08/25/1993 | EP0471718B1 Pharmaceutical composition with a paracetamol base |
08/24/1993 | US5238961 Pgf 1-alcohols and their use as ocular hypotensives |
08/24/1993 | US5238942 Hypotensive agents |
08/24/1993 | US5238932 Mercaptoacetylamide tricyclic derivatives useful as inhibitors of enkephalinase |
08/24/1993 | US5238923 Amino-substituted heterocycles as renin inhibitors |
08/19/1993 | WO1993016068A1 Disubstituted acetylenes bearing heterobicyclic groups and heteroaromatic or phenyl groups having retinoid like activity |
08/19/1993 | WO1993016067A1 Heteroaryl substituted phenylethenyl compounds having retinoid-like biological activity |
08/19/1993 | WO1993015744A1 Bimodal molecular weight hyaluronate formulations and methods for using same |
08/19/1993 | WO1993015608A1 Prevention of retinal injury and degeneration by specific factors |
08/19/1993 | CA2129973A1 Disubstituted acetylenes bearing heterobicyclic groups and heteroaromatic or phenyl groups having retinoid like activity |
08/19/1993 | CA2129831A1 Heteroaryl substituted phenylethenyl compounds having retinoid-like biological activity |
08/19/1993 | CA2129238A1 Bimodal molecular weight hyaluronate formulations and methods for using same |
08/18/1993 | EP0556080A1 Bicyclic pyridine derivatives, process for their preparation, intermediates, their use as medicaments and pharmaceutical compositions containing them |
08/18/1993 | EP0555327A1 Alkylidene analogs of 1'-aminospiro-[isoquinoline- 4(1h),3'-pyrrolidine]-1,2',3,5'(2h)-tetrones useful as aldose reductase inhibitors in vivo |
08/18/1993 | EP0555235A1 Acetylenes disubstituted with a heteroaromatic group and a 2-substituted chromanyl, thiochromanyl or 1,2,3,4-tetrahydroquinolinyl group having retinoid-like activity |
08/17/1993 | US5236951 Administering a phenylethanolamine derivative |
08/10/1993 | US5234927 Magnesium oxide as a biodegradation retarding agent |
08/10/1993 | CA1321199C Chloroaniline derivatives |
08/05/1993 | WO1993014785A1 Immunotherapy for recurrent hsv infections |
08/05/1993 | WO1993014750A2 Amino acids useful as inhibitors of the advanced glycosylation of proteins |
08/05/1993 | WO1993006866A3 Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the cd2/lfa-3 interaction |
08/04/1993 | EP0554107A1 Substituted triazoles as angiotensin II inhibitors |
08/04/1993 | EP0553351A1 CRYSTALLINE MODIFICATION OF HYDROCHLORIDE OF 2-DIMETHYLAMINOETHYL ETHER OF n-BUTYLAMINO BENZOIC ACID, METHOD OF OBTAINING IT AND PHARMACEUTICAL PREPARATION FOR ANESTHESIA OF THE EYE BASED THEREUPON |
08/04/1993 | EP0553263A1 1'-aminospiro-[isoquinoline-4(1h),3'-pyrrolidine]- 1,2',3,5'(2h)-tetrones and analogs thereof useful as aldose reductase inhibitors in vivo |
08/04/1993 | EP0553156A1 Chromans and thiochromans with retinoid-like activity |
08/03/1993 | US5232692 Administering an aqueous solution of povidone-iodine having a specified concentration to the eyes of a human infant to prevent infection by neisseria or chlamydia |
08/01/1993 | CA2088464A1 A new pyridine bicyclic derivatives, process for preparing the same, new intermediates obtained, apllication of the same as drugs, and pharmac eutical compositions containing thesame |
07/31/1993 | CA2088347A1 Substituted triazoles as angiotensin ii inhibitors |
07/29/1993 | DE4201554A1 New benzimidazol-1-yl-methyl-bi:phenyl derivs. |
07/28/1993 | EP0552765A1 Benzimidazoles, pharmaceutical compositions containing them and process for their preparation |
07/28/1993 | EP0552282A1 Bi-aromatic compounds and their use in human and veterinary medecine and in cosmetic preparations. |
07/28/1993 | EP0528861A4 Composition and treatment with biologically active peptides and toxic cations |
07/28/1993 | CN1074606A Method of using M1-selective antimuscarinic pyridobenzodiazepinones in axial myopia therapy |
07/27/1993 | US5231096 Anesthetic for central nervous system |
07/23/1993 | CA2087800A1 Benzimidazoles, pharmaceutical compositions containing these compounds and processes for preparing them |
07/22/1993 | WO1993014112A1 Substituted phosphinic acid-containing peptidyl derivatives as antidegenerative agents |
07/22/1993 | WO1993014090A1 Heterocyclic compounds and their preparation and use |
07/22/1993 | WO1993014089A1 Heterocyclic compounds and their preparation and use |
07/22/1993 | WO1993014077A1 Piperidineacetic acid derivatives as inhibitors of fibrinogen-dependent blood platelet aggregation |